Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study

Abstract Background Efficacy of stereotactic body radiotherapy (SBRT) in stage I non–small-cell lung cancer (NSCLC) has almost been established. In Japan, the protocol of 48 Gy in 4 fractions over 4 days has been most often employed, but higher doses may be necessary to control large tumors. Previou...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Akifumi Miyakawa, Yuta Shibamoto, Fumiya Baba, Yoshihiko Manabe, Taro Murai, Chikao Sugie, Takeshi Yanagi, Taiki Takaoka
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2017-09-01
Serie:	Radiation Oncology
Ämnen:	Non-small-cell lung cancer Stereotactic body radiotherapy Dose escalation Overall survival Toxicity
Länkar:	http://link.springer.com/article/10.1186/s13014-017-0888-7
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!